AzTrials
AzTrials

EmergenciesCTPC15NCT05642117

Pediatric Telephone Center Board 15

An observational study of Emergencies and Pediatric ALL, run by University Hospital, Brest at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the follow-up of advices given in a Urgent Medical Aid Service (SAMU 29) for every pediatric's emergency call under 15yo and try to evaluate the adhesion's factors. Read more about this study

Who is it for?
Ages Up to 15 years
Conditions the study is for
Emergencies, Pediatric ALL, Response, Acute Phase
How many people
785 participants
Where
1 siteFrance
Study dates
1 May 2021to 15 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: all pediatric's emergency call for a child Under 15yo with a medical advice given by the physician.

Who may be able to join

  • all emergency calls at SAMU 29 for under 15yo childs
  • medical advices were given by the physician (medication at home OR consult in an emergency department OR consult the general praticionner the same day or later.

Who cannot join

  • all emergency calls at SAMU 29 for upper 15yo childs
  • participation opposition.
  • need for an ambulance or an emergency medical team at home

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Brest

    Brest, 29609

Other trials in France

About this study

Official title: Pediatric Telephone Center Board 15 and Adhesion Factors

This study evaluates the follow-up of advices given in a Urgent Medical Aid Service (SAMU 29) for every pediatric's emergency call under 15yo and try to evaluate the adhesion's factors.

Read the detailed description

Many of pediatric's medical emergency are followed by a medical advice in a Urgent Medical aid Service (SAMU).

This advices could be medications advices, to see a general praticionner the same day or later, or to consult in an emergency department.

But the rate of advices really followed by callers is unknown. This study evaluate by who, when and why this advices are followed or not.

Keywords
Urgent Medical Aid Service (SAMU), Pediatric
Medical subject headings
Emergencies, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute-Phase Reaction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. rate of medical advices with follow-up completed in epidemic condition

    number of medical advices followed after calling SAMU in epidemic condition

    Measured: 10 days

  2. rate of medical advices with follow-up completed in summer

    number of medical advices followed after calling SAMU in summer

    Measured: 10 days

Secondary outcomes (4)
  1. epidemiology of pediatric's emergency calls in Urgent Medical Aid Service (SAMU 29)

    Who, when and why population calls for an pediatric's emergency probleme

    Measured: 10 days in epidemic condition

  2. epidemiology of pediatric's emergency calls in Urgent Medical Aid Service (SAMU 29)

    Who, when and why population calls for an pediatric's emergency probleme

    Measured: 10 days in summer

  3. adhesion factors to follow medical advice

    By who, when and why medical advices were not followed by callers

    Measured: 10 days in epidemic condition

  4. adhesion factors to follow medical advice

    By who, when and why medical advices were not followed by callers

    Measured: 10 days in summer

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2022
  2. Study start1 May 2021
  3. Primary completion15 Sep 2021
  4. Study completion15 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
785 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05642117
Sponsor's protocol ID
CTPC15 - 29BRC21.0124
Acronym
CTPC15
Status last verified
Dec 2022
First submitted
10 May 2021
Last updated
8 Dec 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Emergencies and Pediatric ALL, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

rate of medical advices with follow-up completed in epidemic condition (time frame: 10 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2022; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in